Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma.

Li, Shuo; Du, Hongbo; Gan, Da'nan; Li, Xiaoke; Zao, Xiaobin; Ye, Yong'an

Li, Shuo; Du, Hongbo; Gan, Da'nan; Li, Xiaoke; Zao, Xiaobin; Ye, Yong'an.

Afiliación

Li S; Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Du H; Institute of Liver Diseases, Beijing University of Chinese Medicine, Beijing, China.
Gan D; Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Li X; Institute of Liver Diseases, Beijing University of Chinese Medicine, Beijing, China.
Zao X; Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Ye Y; Institute of Liver Diseases, Beijing University of Chinese Medicine, Beijing, China.

Front Pharmacol ; 14: 1200114, 2023.

Article en En | MEDLINE | ID: mdl-37397471

Palabras clave

ScRNA-seq; hepatocellular carcinoma; immune microenvironment; natural killer cells; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google